News
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
The drastic cost-cutting move follows the deaths of two teenagers that forced the company to restrict usage of its gene therapy for Duchenne muscular dystrophy.
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...
Weight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...
So much information surrounds weight-loss jabs and so understanding what to expect from them can feel daunting ...
Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss ...
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results